- Filed
- Mar 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 3, 2025 | 18.98M sh |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $35M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $72.91M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $240.08M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $323.91M |
| Current Assets | FY 2024 · Dec 31, 2023 | $216M |
| Total Assets | FY 2024 · Dec 31, 2023 | $564.17M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 19.17M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $15.11M |
| Capex | FY 2024 · Dec 31, 2022 | $5.66M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $39.43M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $1.14 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $1.15 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $278.52M |
| Net Income | FY 2024 · Dec 31, 2022 | $21.81M |
| Operating Income | FY 2024 · Dec 31, 2022 | $32.65M |
| Revenue | FY 2024 · Dec 31, 2022 | $537.79M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $203.91M |